X. Pivot
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
-
- Medical Imaging and Pathology Studies 1
- Oncology 5
- HER2/EGFR in Cancer Research 2
- Cancer Diagnosis and Treatment 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Jean-Philippe Jacquin (1 shared paper)Andrew Kramar (1 shared paper)Thomas Bachelot (1 shared paper)Christelle Jouannaud (1 shared paper)Jean‐Yves Pierga (1 shared paper)Marc Espié (1 shared paper)Marc Debled (1 shared paper)Pierre Kerbrat (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Cancer (1 paper)Advanced Therapeutics (1 paper)The Lancet Oncology (1 paper)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
X. Pivot
11 papers receiving 310 citations
Peers
Comparison fields: 5 of 43
- Otorhinolaryngology 42
- Oncology 230
- Cancer Research 94
- Radiology, Nuclear Medicine and Imaging 94
- Pulmonary and Respiratory Medicine 83
Countries citing papers authored by X. Pivot
This map shows the geographic impact of X. Pivot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Pivot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Pivot more than expected).
Fields of papers citing papers by X. Pivot
This network shows the impact of papers produced by X. Pivot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Pivot. The network helps show where X. Pivot may publish in the future.
Co-authors
The 25 scholars most cited alongside X. Pivot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 211 | |
| 2 | 2004 | 42 | |
| 3 | 1997 | 21 | |
| 4 | 2003 | 15 | |
| 5 | 2019 | 12 | |
| 6 | 2023 | 7 | |
| 7 | [Vertebral osteosarcoma. Review of the literature apropos of a case]. | 1995 | 4 |
| 8 | 2015 | 3 | |
| 9 | 2016 | 3 | |
| 10 | [Severe hypocalcemia after treatment with diphosphonates and aminoglycosides]. | 1994 | 2 |
| 11 | 2012 | 1 |
About X. Pivot
X. Pivot is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Otorhinolaryngology and Pathology and Forensic Medicine, having authored 11 papers that have together received 321 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (2 papers), Head and Neck Cancer Studies (2 papers), Cancer Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (1 paper), Nanoplatforms for cancer theranostics (1 paper), Allergic Rhinitis and Sensitization (1 paper), Medical Imaging and Pathology Studies (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Otorhinolaryngology (42 citations), Oncology (230 citations), Cancer Research (94 citations), Radiology, Nuclear Medicine and Imaging (94 citations) and Pulmonary and Respiratory Medicine (83 citations). X. Pivot has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Jean-Philippe Jacquin, Andrew Kramar, Thomas Bachelot, Christelle Jouannaud, Jean‐Yves Pierga, Marc Espié, Marc Debled, Pierre Kerbrat, Iris Pauporté and David Khayat. Their work appears in journals such as Annals of Oncology, Cancer, Advanced Therapeutics, The Lancet Oncology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.